Real-world data reveals differences between diagnoses and phenotypes, and how polypharmacy affects functioning in patients.

Holmusk offers new insights on the association between comorbid substance use disorders and illness severity in people with schizophrenia.

Holmusk offers new real-world evidence into patients with difficult-to-treat depression.

Holmusk publishes paper in BMJ Open, centering on dataset available in NeuroBlu, and platform capabilities.

Holmusk provides new insights into schizophrenia that could support more individualized care pathways.

Expanded dataset to enhance real-world impact. Boost efficiency with Help & Resources.

Filter search results and view data by categories. Download cohort visualizations to document your research.

Holmusk presents results from the largest analysis to date evaluating treatment of ADHD for young children.

Study uses Real-World Data to describe important patterns in the treatment of opioid use disorder.

Build dynamic risk models. New functions in Code Studio to conduct research studies faster.

Holmusk publishes abstract in American Academy of Child and Adolescent Psychiatry (AACAP) 68th Annual Meeting.

Enhanced experience with smoother onboarding journey, new CGI-S filter and new project organization tools.

Holmusk presents at American Society for Clinical Pathology (ASCP) 2021 Annual Meeting.

Holmusk invites start-ups and academics to submit proposals for projects using NeuroBlu.

Use Python to perform customized research studies on NeuroBlu.

Conduct advanced analytics with ease, with enhanced visualizations and documentation of research notes.